Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ZICCUM to publish White Paper on world’s first industrial air-drying of vaccines using its LaminarPace technology

The White Paper will describe in detail the integration of Ziccum AB’s LaminarPace technology into a Fill and Finish (F/F) manufacturing facility of the world’s first plant for formulating and packaging thermostable air-dried vaccines at volume. The new vaccines could be produced at an estimated -65% lower OPEX and -50% lower CAPEX cost than today’s freeze drying (lyophilization) F/F plants. The vaccines produced could be stored and transported at ambient temperatures, requiring no Cold Chain.The vast majority of today’s F/F plants – the final stage in vaccine manufacture and distribution -

Calliditas Announces Poster and Presentation at ASN Digital Kidney Week 2020

Calliditas Therapeutics AB (publ) (”Calliditas”) today announced upcoming presentations concerning Nefecon, its lead product candidate, at the American Society of Nephrology (ASN) Kidney Week 2020 Reimagined conference, to be held virtually October 19–25, 2020.At the "Glomerular Diseases: Clinical, Outcomes, and Trials” session, a poster will be presented by Professor Jonathan Barratt from the Mayer IgA Nephropathy Laboratory at the University of Leicester. The poster describes the design of the NefIgArd trial, which is exploring the effect of Nefecon in patients with IgA Nephropathy (IgAN)

Trixeo Aerosphere receives positive CHMP opinion

19 October 2020 07:00 BST Trixeo Aerosphere recommended for approval in the EUby CHMP for the maintenance treatment of COPD Recommendation of triple-combination therapy based onpositive results from ETHOS and KRONOS Phase III trials AstraZeneca's Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled

Forxiga HF receives positive CHMP opinion

19 October 2020 07:00 BST Forxiga recommended for approval in the EU by CHMP for heart failure If approved, Forxiga would become the first SGLT2 inhibitor indicated for heart failure with reduced ejection fraction in patients with and without type-2 diabetes AstraZeneca's Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF) in adults with and without type-2 diabetes (T2D). Heart failure (HF) is a life-threatening

Press Release: Everfuel contemplates private placement and listing on Merkur Market

Everfuel A/S (Everfuel), a minority-owned company of Nel ASA (Nel) is contemplating a private placement and admission to trading on Merkur Market, which is part of the Oslo Stock Exchange. "We’re happy to see the positive development Everfuel has made over the last year and a half, and with the plans the company has for further expansions in the near future, we see this development as very positive," says Jon André Løkke, CEO of Nel. Nel holds a 19.9% ownership in Everfuel, and has pre-committed to subscribe shares in the private placement, equal to around EUR 0.8 million. Link to

Everfuel A/S: Contemplated private placement and admission to trading of leading European green hydrogen fuel company on Merkur Market

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Herning, 19 October 2020 – Everfuel A/S (“Everfuel” or the “Company”) has engaged SpareBank 1 Markets AS (the “Manager”) to advise on and carry out a private placement of up to 13,200,000 million new shares in the Company (the “Private Placement”) raising gross

Selvaag Bolig ASA: Management changes at Selvaag Bolig

Rolf Thorsen is stepping down as CEO of Selvaag Bolig ASA. He is being replaced by Sverre Molvik as CEO and Øystein Klungland as COO.   Following an evaluation process, Thorsen and the board have come to the conclusion that he will step down with immediate effect after leading the company since May 2019. “Thorsen’s time with the company has proved shorter than we had planned,” says chair Olav H Selvaag. “Nevertheless, I’d like to thank him for our collaboration during the time we’ve worked together.” Molvik is taking over as CEO immediately. He has been with the company for 10

Targovax announces accepted abstract at SITC

Oslo, Norway, 19 October 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announces that an abstract on the mesothelioma trial has been accepted and will be presented at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting, 9 -14 November 2020.The abstract presents the 12-month analysis of biomarkers and clinical outcome from the phase I/II trial in malignant pleural mesothelioma where ONCOS-102 is added to standard of care chemotherapy (pemetrexed / cisplatin). This

Axfoundation's integration initiative accelerates: ÖppnaDörren becomes part of Axel Johnson

ÖppnaDörren is taking the next step in creating a movement of ‘door openers’ who all contribute to a more open Sweden. Axfoundation's innovative integration initiative becomes part of Axelerate, Axel Johnson Group's newly started focus area to fast track efforts within the areas of diversity and inclusion. Since Axfoundation started ÖppnaDörren in 2015, over 59,000 new and established Swedes have met over dinner, coffee or with their children – and 24 percent have found a job or an internship as a result of the meeting. This shows that our approach to change works in practice: Meetings lead

Lundin Mining Provides Update on Labour Action at Candelaria

Toronto, ON, October 18, 2020 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) announced today that despite mediation with the Candelaria AOS Union (the “Union”), which represents approximately 550 workers at its Candelaria operations in Chile, the Company and the Union have failed to reach an agreement. The Union can legally be on strike commencing October 20, 2020. The Candelaria Mine Workers Union continues with its labour action which commenced on October 8, 2020. Lundin Mining holds health and safety as a top priority in

Orkla ASA: Mandatory Notification of trade – Adjusted number of Shares for Employees 2020

Reference is made to the stock exchange notice of 5 October 2020 regarding Shares for Employees 2020.The number of Orkla shares transferred to Orkla employees in connection with the share purchase programme has been adjusted. As a result, Orkla has transferred 2,200 shares in addition to the 621,182 shares which were transferred on the 5[th] of October.After this transaction Orkla owns 501,800 treasury shares.Orkla ASAOslo, 18 October 2020Ref.:Investor RelationsElise HeidenreichTel: +47 951 41 147Email: elise.andersen.heidenreich@orkla.no

Intrum appoints Anders Engdahl as new President and CEO and announces a strong third quarter result

The Board of Directors of Intrum AB (publ) has today come to an agreement with Mikael Ericson who will leave the company after four years as President and CEO. At the same time, the Board has appointed Intrum’s current Chief Financial Officer Anders Engdahl as new President and CEO when the company now enters into its next phase. Anders Engdahl assumes the position with immediate effect. By reason of the CEO change, the Board has decided to announce the preliminary result for the third quarter, which is expected to be substantially above the analyst consensus.“The past few years have been

Why India needs to solve the water pollution issue

Environmental, health and ecosystem vitality are fast becoming key concerns in India. The industrial sector is facing pressure on several fronts to address issues of increased water consumption and water pollution. As water is becoming an increasingly scarce resource, the continued growth of India’s economy will translate into increased demand for wastewater treatment solutions across different sectors. In 2019, a World Resources Institute (WRI) report  ranked India as

Picosun’s success brings Chairman of the Board Kustaa Poutiainen the National Entrepreneur Award of Finland 2020

ESPOO, Finland, 17[th] October 2020 – The Chairman of the Board and founder of Picosun Group, Mr. Kustaa Poutiainen, has been awarded as Finland’s Entrepreneur of the Year 2020. Mr. Poutiainen received the National Entrepreneur Award in the annual meeting of the Federation of Finnish Enterprises in Jyväskylä on 17[th] October. The award is given every year to four Finnish entrepreneurs as a recognition of exceptional entrepreneurship. Picosun provides ALD (Atomic Layer Deposition) thin film coating solutions to global microelectronics and other industries. ALD was invented in Finland in

Gunnar Groebler leaves Vattenfall to become CEO of Salzgitter AG

Senior Vice President and Head of Vattenfall’s Business Area Wind, Gunnar Groebler, will leave Vattenfall during the spring of 2021 to become CEO of the German steel and technology company Salzgitter AG.Gunnar Groebler joined Vattenfall in 1999 and has been essential in making Vattenfall a leading company in renewable energy production.  “After 21 exciting and rewarding years at Vattenfall, I have decided to move on. I´m looking back to a great journey, developing the Vattenfall Wind and Solar business to one of the leaders in this industry and strongly underlining Vattenfall´s leading

Emapalumab’s efficacy confirmed by sensitivity analysis presented at ESID2020

· Treatment goal in primary haemophagocytic lymphohistiocytosis (HLH), a rare and life-threatening disorder, is to stabilise the disease and bring patients to haematopoietic stem cell transplantation (HSCT), the only curative therapy · Unmet medical need remains high, with current standard-of-care therapy associated with adverse events and no decrease in mortality rates in the past 20 years · Pivotal study of emapalumab in primary HLH patients who had no satisfactory response to prior treatments, was the first HLH study to use clinically objective response criteria · Data from

Stabilisation notice, partial exercise of over-allotment option and end of the stabilisation period

ABG Sundal Collier AB (“ABGSC”), in its capacity as Sole Global Coordinator, notifies that stabilisation measures have been undertaken in Readly International AB's (publ) (“Readly” or the “Company”) shares traded on Nasdaq Stockholm. ABGSC further announces that the stabilisation period has now ended and no further stabilisation transactions will be effected. The over-allotment option is partially exercised by ABGSC, which means that 630,000 shares have been exercised and 1,200,508 shares, that ABGSC has lent from the Main Shareholder[1]  in order to cover the over-allotment,

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 16.10.2020

United Bankers Corporation NOTIFICATION 16.10.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 16.10.2020 Date 16.10.2020Exchange transaction BuyShare class UNIAVAmount 437Average price/share 9.3000 EURHighest price/share 9.3000 EURLowest price/share 9.3000 EURTotal price 4,064.10 EUR The shares held by United Bankers Corporation on 16.10.2020: UNIAV 23,104   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

NIXU CORPORATION SHARE REPURCHASE 16.10.2020

NIXU CORPORATION ANNOUNCEMENT  16.10.2020 NIXU CORPORATION SHARE REPURCHASE 16.10.2020 In the Helsinki Stock Exchange Trade date           16.10.2020Bourse trade         BuyShare                  NIXUAmount             2 500 SharesAverage price/ share    8,6450 EURTotal cost            21 612,50 EUR Nixu Corporation now holds a total of 17 405 sharesincluding the shares repurchased on 16.10.2020 On behalf of

THE SUBSCRIPTION PERIOD IN KEBNI AB'S (PUBL) RIGHTS ISSUE OF UP TO SEK 50 MILLION COMMENCES

Today marks the start of the subscription period in KebNi AB (publ) ("KebNi" or the "Company") rights issue of shares. The rights issue is also open for subscriptions to the public.This press release may not be announced, published or distributed, in whole or in part, directly or indirectly, in the United States, Canada, Japan, Australia, Hong Kong, New Zealand, Singapore, South Africa or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be prepared or registered or require any other actions to be taken,

#20-371 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Samhällsbyggnadsbolaget i Norden AB (publ) announces early redemption of the outstanding senior unsecured floating rate notes with ISIN SE0010414581

Samhällsbyggnadsbolaget i Norden AB (publ) (the "Issuer") today announces early redemption of the outstanding senior unsecured floating rate notes with ISIN SE0010414581 (the "Notes"). The Notes are currently listed on the Corporate Bond List of Nasdaq Stockholm. The Issuer has today, through the agent of the Notes Nordic Trustee & Agency AB (publ), notified the holders of the Notes (the "Noteholders") that the Notes will be redeemed in full on 18 November 2020 (the "Early Redemption"). The Early Redemption is made in accordance with Clause 9.3 (Early redemption (call option)) in the terms

DBP International AB: participate in semi-final of EIT Health Catapult 2020

Double Bond Pharmaceutical International AB (publ) (“Double Bond Pharmaceutical” eller “DBP”) was selected to pitch in the EIT Health Catapult semifinals in the biotech sector. The CEO Igor Lokot will present the company on Wednesday, October 21 at 10:45. Register for free to attend this year’s virtual pitch:  https://www.europeanhealthcatapult.eu/register-for-semifinals. “Double Bond Pharmaceutical provides unique investment opportunity: our ambitious team made a huge work in the development of SI-053 as a game-changer for treatment of malignancies in the brain; now I need to

One RescueRunner ordered by the Swedish Sea Rescue Society (SSRS)

The Swedish Sea Rescue Society (SSRS) order a RescueRunner and further expand their fleet of RescueRunners.SSRS once developed the RescueRunner for rescue missions in shallow and rocky areas where other boats cannot go, and today there are over 60 RescueRunners in operation at their 69 rescue stations in Sweden. Many of SSRS RescueRunners have been in operation for over 10 years and have helped save many lives. The order will further increase their capacity to save lives at sea. SSRS is not only a customer to Safe at Sea, they are also a partner when it comes to development and training.

There are no items matching the current filter
There are no more items matching the current filter
Back to top